PLoS Pathogens · 2007 · 326 citations · 31 references
Life SciencesGeneticsMicrobiologyApoptosisHost-pathogen InteractionsMicrobial PathogenesisApoptosis ModulationInnate Immune Signaling PathwaysMacrophage BiologyPulmonary TuberculosisVirulence Gene RegulationAnti-apoptotic BalanceAnti-apoptotic RegulatorsApoptosis In Bacterial InfectionApoptosis In InfectionMacrophage ApoptosisMycobacterium Tuberculosis InfectionMycobacterium Tuberculosis PathogenesisVirulence Gene Expression
The survival and persistence of Mycobacterium tuberculosis depends on its capacity to manipulate multiple host defense pathways, including the ability to actively inhibit the death by apoptosis of infected host cells. The genetic basis for this anti-apoptotic activity and its implication for mycobacterial virulence have not been demonstrated or elucidated. Using a novel gain-of-function genetic screen, we demonstrated that inhibition of infection-induced apoptosis of macrophages is controlled by multiple genetic loci in M. tuberculosis. Characterization of one of these loci in detail revealed that the anti-apoptosis activity was attributable to the type I NADH-dehydrogenase of M. tuberculosis, and was mainly due to the subunit of this multicomponent complex encoded by the nuoG gene. Expression of M. tuberculosis nuoG in nonpathogenic mycobacteria endowed them with the ability to inhibit apoptosis of infected human or mouse macrophages, and increased their virulence in a SCID mouse model. Conversely, deletion of nuoG in M. tuberculosis ablated its ability to inhibit macrophage apoptosis and significantly reduced its virulence in mice. These results identify a key component of the genetic basis for an important virulence trait of M. tuberculosis and support a direct causal relationship between virulence of pathogenic mycobacteria and their ability to inhibit macrophage apoptosis.
31
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Stewart T. Cole, Roland Brosch, Julian Parkhill et al. · Nature · 1998 · 7.9K citations · Full text
New use of BCG for recombinant vaccines
C. Kendall Stover, Vidal F. de la Cruz, Thomas R. Fuerst et al. · Nature · 1991 · 1.5K citations